Centro de Investigación en Medicina Molecular e Enfermidades Crónicas (CIMUS)
Einzigartiges Zentrum
Instituto de Investigación Sanitaria de Navarra
Pamplona, EspañaPublikationen in Zusammenarbeit mit Forschern von Instituto de Investigación Sanitaria de Navarra (8)
2024
2023
-
Targeted siRNA lipid nanoparticles for the treatment of KRAS-mutant tumors
Journal of Controlled Release, Vol. 357, pp. 67-83
-
The outcome of boosting mitochondrial activity in alcohol-associated liver disease is organ-dependent
Hepatology (Baltimore, Md.), Vol. 78, Núm. 3, pp. 878-895
2022
-
Metabolic-associated fatty liver disease: From simple steatosis toward liver cirrhosis and potential complications. Proceedings of the Third Translational Hepatology Meeting, organized by the Spanish Association for the Study of the Liver (AEEH)
Gastroenterologia y Hepatologia, Vol. 45, Núm. 9, pp. 724-734
2021
-
Glucocerebrosidase gene therapy induces alpha-synuclein clearance and neuroprotection of midbrain dopaminergic neurons in mice and macaques
International Journal of Molecular Sciences, Vol. 22, Núm. 9
-
The first wave of the COVID-19 epidemic in Spain was associated with early introductions and fast spread of a dominating genetic variant
Nature Genetics, Vol. 53, Núm. 10, pp. 1405-1414
2018
-
Gene therapy approaches in the non-human primate model of Parkinson’s disease
Journal of Neural Transmission, Vol. 125, Núm. 3, pp. 575-589
-
Matrix metalloproteinase-10 deficiency delays atherosclerosis progression and plaque calcification
Atherosclerosis, Vol. 278, pp. 124-134